Pipeline

Healing, Activated On Demand.

Umbilical cord-derived mesenchymal stem cells (MSCs), particularly those sourced from Wharton’s Jelly, represent a powerful platform for regenerative medicine due to their unique biological properties and therapeutic versatility. These cells primarily exert their effects by secreting a broad range of growth factors, cytokines, and extracellular vesicles that reduce inflammation, promote tissue repair, enhance blood vessel formation, and support the survival and regeneration of native cells. Unlike many adult-derived cell sources, Wharton’s Jelly MSCs are highly proliferative and exhibit low immunogenicity, enabling allogeneic, off-the-shelf use without the need for donor matching. They also possess the ability to orchestrate repair across multiple tissue types, including the central nervous system. Axiom amplifies the therapeutic potential of these cells through controlled pre-conditioning and engineering strategies to unlock the full potential of MSCs as a scalable and impactful solution in regenerative medicine.